Joyce A. Sutcliffe

6.9k total citations · 3 hit papers
68 papers, 5.7k citations indexed

About

Joyce A. Sutcliffe is a scholar working on Molecular Biology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Joyce A. Sutcliffe has authored 68 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 26 papers in Molecular Medicine and 23 papers in Epidemiology. Recurrent topics in Joyce A. Sutcliffe's work include Antibiotic Resistance in Bacteria (26 papers), Antimicrobial Resistance in Staphylococcus (16 papers) and Pneumonia and Respiratory Infections (14 papers). Joyce A. Sutcliffe is often cited by papers focused on Antibiotic Resistance in Bacteria (26 papers), Antimicrobial Resistance in Staphylococcus (16 papers) and Pneumonia and Respiratory Infections (14 papers). Joyce A. Sutcliffe collaborates with scholars based in United States, Japan and Germany. Joyce A. Sutcliffe's co-authors include Amelia Tait‐Kamradt, L Wondrack, Patrice Courvalin, Corey Fyfe, Julian I. Rood, Lars Jensen, Helena Seppälä, Marilyn C. Roberts, Trudy H. Grossman and William J. O’Brien and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Bacteriology and Annals of the New York Academy of Sciences.

In The Last Decade

Joyce A. Sutcliffe

68 papers receiving 5.4k citations

Hit Papers

Detection of erythromycin-resistant determinants by PCR 1996 2026 2006 2016 1996 1999 1996 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Detection of erythromycin-resistant determinants by PCR
    1996 866 citations Joyce A. Sutcliffe, Amelia Tait‐Kamradt et al. Antimicrobial Agents and Chemotherapy profile →
  2. Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants
    1999 685 citations Joyce A. Sutcliffe et al. Antimicrobial Agents and Chemotherapy profile →
  3. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system
    1996 537 citations Joyce A. Sutcliffe, Amelia Tait‐Kamradt et al. Antimicrobial Agents and Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joyce A. Sutcliffe United States 36 2.1k 2.0k 1.8k 1.5k 1.3k 68 5.7k
Douglas J. Biedenbach United States 44 2.0k 0.9× 2.2k 1.1× 2.9k 1.6× 799 0.5× 1.9k 1.5× 153 6.1k
Yoshichika Arakawa Japan 50 2.7k 1.3× 1.5k 0.7× 5.3k 2.9× 2.1k 1.5× 1.3k 1.0× 247 8.9k
Philippe Lagacé‐Wiens Canada 38 1.7k 0.8× 1.3k 0.6× 2.9k 1.6× 794 0.5× 1.8k 1.4× 126 5.3k
Franz‐Josef Schmitz Germany 34 1.1k 0.5× 2.4k 1.2× 1.4k 0.8× 1.4k 1.0× 772 0.6× 60 4.4k
Ian Morrissey United Kingdom 32 1.4k 0.7× 824 0.4× 1.4k 0.8× 743 0.5× 969 0.8× 116 3.5k
Jan Bell Australia 39 1.2k 0.6× 3.3k 1.6× 2.3k 1.2× 2.0k 1.4× 756 0.6× 123 6.2k
Ian A. Critchley United States 41 2.0k 1.0× 1.5k 0.7× 1.4k 0.8× 778 0.5× 1.4k 1.1× 119 4.2k
Jana M. Swenson United States 39 2.6k 1.3× 2.8k 1.4× 1.1k 0.6× 942 0.6× 678 0.5× 84 5.6k
Sebastián Albertí Spain 44 1.1k 0.5× 870 0.4× 4.1k 2.3× 1.7k 1.2× 1.0k 0.8× 97 6.4k
Niels Frimodt‐Møller Denmark 38 1.4k 0.7× 736 0.4× 1.4k 0.8× 1.6k 1.1× 868 0.7× 142 4.8k

Countries citing papers authored by Joyce A. Sutcliffe

Since Specialization
Citations

This map shows the geographic impact of Joyce A. Sutcliffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce A. Sutcliffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce A. Sutcliffe more than expected).

Fields of papers citing papers by Joyce A. Sutcliffe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce A. Sutcliffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce A. Sutcliffe. The network helps show where Joyce A. Sutcliffe may publish in the future.

Co-authorship network of co-authors of Joyce A. Sutcliffe

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce A. Sutcliffe. A scholar is included among the top collaborators of Joyce A. Sutcliffe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce A. Sutcliffe. Joyce A. Sutcliffe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sutcliffe, Joyce A., Robert E. McLaughlin, Guy Webster, et al.. (2020). Susceptibility of Cutibacterium acnes to topical minocycline foam. Anaerobe. 62. 102169–102169. 14 indexed citations
2.
Zhanel, George G., Melanie Baxter, Heather J. Adam, Joyce A. Sutcliffe, & James A. Karlowsky. (2017). In vitro activity of eravacycline against 2213 Gram-negative and 2424 Gram-positive bacterial pathogens isolated in Canadian hospital laboratories: CANWARD surveillance study 2014–2015. Diagnostic Microbiology and Infectious Disease. 91(1). 55–62. 63 indexed citations
3.
Sun, Cuixiang, Diana K. Hunt, Corey Fyfe, et al.. (2017). Heterocyclyl tetracyclines. 2. 7-Methoxy-8-pyrrolidinyltetracyclines: discovery of TP-2758, a potent, orally efficacious antimicrobial against Gram-negative pathogens. The Journal of Antibiotics. 71(2). 287–297. 5 indexed citations
4.
Fyfe, Corey, et al.. (2016). Resistance to Macrolide Antibiotics in Public Health Pathogens. Cold Spring Harbor Perspectives in Medicine. 6(10). a025395–a025395. 166 indexed citations
5.
Fyfe, Corey, Joyce A. Sutcliffe, & Trudy H. Grossman. (2012). Development and characterization of a Pseudomonas aeruginosa in vitro coupled transcription–translation assay system for evaluation of translation inhibitors. Journal of Microbiological Methods. 90(3). 256–261. 5 indexed citations
6.
Hamouda, Tarek, Joyce A. Sutcliffe, Susan Ciotti, & James R. Baker. (2011). Intranasal Immunization of Ferrets with Commercial Trivalent Influenza Vaccines Formulated in a Nanoemulsion-Based Adjuvant. Clinical and Vaccine Immunology. 18(7). 1167–1175. 37 indexed citations
7.
Hamouda, Tarek, А. А. Чепурнов, Nicholas Mank, et al.. (2010). Efficacy, immunogenicity and stability of a novel intranasal Nanoemulsion-adjuvanted influenza vaccine in a murine model. Human Vaccines. 6(7). 585–594. 32 indexed citations
8.
Skripkin, Eugene, Timothy McConnell, Joseph A. DeVito, et al.. (2008). Rχ-01, a New Family of Oxazolidinones That Overcome Ribosome-Based Linezolid Resistance. Antimicrobial Agents and Chemotherapy. 52(10). 3550–3557. 61 indexed citations
9.
Sutcliffe, Joyce A.. (2008). Novel Nanoemulsion Antimicrobials Tested Against Nine Gram-Positive Species. 46th Annual Meeting. 5 indexed citations
10.
Sutcliffe, Joyce A.. (2005). Improving on nature: antibiotics that target the ribosome. Current Opinion in Microbiology. 8(5). 534–542. 71 indexed citations
11.
Franceschi, F., Z.F. Kanyo, Edward C. Sherer, & Joyce A. Sutcliffe. (2004). Macrolide Resistance from the Ribosome Perspective. PubMed. 4(3). 177–191. 51 indexed citations
12.
Butler, Jay C., Jeffrey L. Lennox, Linda K. McDougal, et al.. (2003). Macrolide‐Resistant Pneumococcal Endocarditis and Epidural Abscess that Develop during Erythromycin Therapy. Clinical Infectious Diseases. 36(2). e19–e25. 17 indexed citations
13.
Sugie, Yutaka, Koen Dekker, TAISUKE INAGAKI, et al.. (2002). A Novel Antibiotic CJ-17,572 from a Fungus, Pezicula sp.. The Journal of Antibiotics. 55(1). 19–24. 22 indexed citations
14.
Sakemi, Shinichi, Jon Bordner, Koen Dekker, et al.. (2002). CJ-15,696 and Its Analogs, New Furopyridine Antibiotics from the Fungus Cladobotryum varium: Fermentation, Isolation, Structural Elucidation, Biotransformation and Antibacterial Activities.. The Journal of Antibiotics. 55(1). 6–18. 36 indexed citations
15.
Sugie, Yutaka, Koen Dekker, Hideo Hirai, et al.. (2001). CJ-15,801, a Novel Antibiotic from a Fungus, Seimatosporium sp.. The Journal of Antibiotics. 54(12). 1060–1065. 34 indexed citations
16.
Sugie, Yutaka, Hideo Hirai, TAISUKE INAGAKI, et al.. (2001). A New Antibiotic CJ-17,665 from Aspergillus ochraceus.. The Journal of Antibiotics. 54(11). 911–916. 89 indexed citations
17.
Sugie, Yutaka, Hideo Hirai, Yoon-Jeong Kim, et al.. (2001). New Pyrrolizidinone Antibiotics CJ-16,264 and CJ-16,367.. The Journal of Antibiotics. 54(11). 917–925. 33 indexed citations
18.
Syrogiannopoulos, George A., Ioanna N. Grivea, Amelia Tait‐Kamradt, et al.. (2001). Identification of an erm (A) Erythromycin Resistance Methylase Gene in Streptococcus pneumoniae Isolated in Greece. Antimicrobial Agents and Chemotherapy. 45(1). 342–344. 53 indexed citations
19.
INAGAKI, TAISUKE, Yumiko Suzuki, Hideo Hirai, et al.. (1998). CJ-12,373, a Novel Topoisomerase II Inhibitor: Fermentation, Isolation, Structure Elucidation and Biological Activities.. The Journal of Antibiotics. 51(2). 112–116. 27 indexed citations
20.
Gootz, Thomas D., et al.. (1994). In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial. Diagnostic Microbiology and Infectious Disease. 19(4). 235–243. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Douglas J. Biedenbach Breakdown of academic impact, for papers by Yoshichika Arakawa Breakdown of academic impact, for papers by Philippe Lagacé‐Wiens Breakdown of academic impact, for papers by Franz‐Josef Schmitz Breakdown of academic impact, for papers by Ian Morrissey Breakdown of academic impact, for papers by Jan Bell Breakdown of academic impact, for papers by Ian A. Critchley Breakdown of academic impact, for papers by Jana M. Swenson Breakdown of academic impact, for papers by Sebastián Albertí Breakdown of academic impact, for papers by Niels Frimodt‐Møller
Rankless by CCL
2026